Literature DB >> 24394475

Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study.

Antoine Adenis1, Mathieu Nacher, Matthieu Hanf, Célia Basurko, Julie Dufour, Florence Huber, Christine Aznar, Bernard Carme, Pierre Couppie.   

Abstract

In disease-endemic areas, histoplasmosis is the main differential diagnosis for tuberculosis among human immunodeficiency virus (HIV)-infected patients. However, no study has compared the two diseases. Thus, the objective of this study was to compare tuberculosis and histoplasmosis in HIV-infected patients. A population of 205 HIV-infected patients (99 with tuberculosis and 106 with histoplasmosis) hospitalized in Cayenne, French Guiana during January 1, 1997-December 31, 2008 were selected retrospectively from the French Hospital Database on HIV. Multivariate analysis showed that tuberculosis was associated with cough (adjusted odds ratio [AOR] = 0.20, 95% confidence interval [CI] = 0.05-0.73) and a C-reactive protein level > 70 mg/L (AOR = 0.98, 95% CI = 0.97-0.99). Variables associated with disseminated histoplasmosis were a γ-glutamyl transferase level > 72 IU/L (AOR = 4.99, 95% CI = 1.31-18.99), origin from French Guiana (AOR = 5.20, 95% CI = 1.30-20.73), disseminated localization (AOR = 6.40, 95% CI = 1.44-28.45), a concomitant opportunistic infection (AOR = 6.71, 95% CI = 1.50-29.96), a neutrophil count < 2,750 cells/mm(3) (AOR = 10.54, 95% CI = 2.83-39.24), a CD4 cell count < 60 cells/mm(3) (AOR = 11.62, 95% CI = 2.30-58.63), and a platelet count < 150,000/mm(3) (AOR = 19.20, 95% CI = 3.35-110.14). Tuberculosis and histoplasmosis have similarities, but some factors show a greater association with one of these diseases. Thus, adapted therapeutic choices can be made by using simple clinical and paraclinical criteria.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24394475      PMCID: PMC3919221          DOI: 10.4269/ajtmh.13-0084

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Extrapulmonary tuberculosis masking disseminated histoplasmosis in AIDS.

Authors:  L Greene; B Peters; S B Lucas; A L Pozniak
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

Review 2.  Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Authors:  L J Wheat; P A Connolly-Stringfield; R L Baker; M F Curfman; M E Eads; K S Israel; S A Norris; D H Webb; M L Zeckel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

3.  Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors.

Authors:  Pierre Couppié; Milko Sobesky; Christine Aznar; Saravane Bichat; Emmanuel Clyti; François Bissuel; Myriam El Guedj; Fernand Alvarez; Magali Demar; Dominique Louvel; Roger Pradinaud; Bernard Carme
Journal:  Clin Infect Dis       Date:  2003-12-04       Impact factor: 9.079

4.  Sporadic disseminated histoplasmosis simulating miliary tuberculosis.

Authors:  P Tong; W C Tan; M Pang
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-17

5.  Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection.

Authors:  R J Hay; H S White; P E Fields; D B Quamina; M Dan; T R Jones
Journal:  J Trop Med Hyg       Date:  1981-02

6.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

7.  A computer program for stepwise logistic regression using maximum likelihood estimation.

Authors:  D W Hosmer; C Y Wang; I C Lin; S Lemeshow
Journal:  Comput Programs Biomed       Date:  1978-06

8.  Case report: Esophageal histoplasmosis associated with disseminated tuberculosis in acquired immunodeficiency syndrome.

Authors:  Rosamar Eulira Fontes Rezende; Mariângela Ottoboni Brunaldi; Milena Santana Girão; Sérgio Zucoloto; Sérgio Britto Garcia; Alcyone Artioli Machado; José Luiz Pimenta Módena
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

9.  Disseminated histoplasmosis mimicking miliary tuberculosis: a case report.

Authors:  K S Chan; L M Looi; S P Chan
Journal:  Malays J Pathol       Date:  1993-12       Impact factor: 0.656

10.  Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.

Authors:  B E Jones; S M Young; D Antoniskis; P T Davidson; F Kramer; P F Barnes
Journal:  Am Rev Respir Dis       Date:  1993-11
View more
  30 in total

1.  Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Authors:  Diego H Caceres; Angela M Tobón; Angela Ahlquist Cleveland; Christina M Scheel; Dedsy Y Berbesi; Jesús Ochoa; Angela Restrepo; Mary E Brandt; Tom Chiller; Beatriz L Gómez
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

2.  Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries.

Authors:  Diego H Cáceres; Blanca E Samayoa; Eduardo E Arathoon; Beatriz L Gómez; Narda G Medina; Angela M Tobón; Brenda J Guzmán; Danicela Mercado; Angela Restrepo; Tom Chiller
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

Review 3.  Diagnosis of histoplasmosis: current status and perspectives.

Authors:  María Agustina Toscanini; Alejandro David Nusblat; María Luján Cuestas
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

4.  HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease.

Authors:  B Crabtree-Ramírez; C Jenkins; K Jayathilake; G Carriquiry; V Veloso; D Padgett; E Gotuzzo; C Cortes; F Mejia; C C McGowan; S Duda; B E Shepherd; T R Sterling
Journal:  Int J Tuberc Lung Dis       Date:  2019-03-01       Impact factor: 2.373

5.  Histoplasma capsulatum 100-kilodalton antigen: recombinant production, characterization, and evaluation of its possible application in the diagnosis of histoplasmosis.

Authors:  María A Toscanini; Daniel González Maglio; Paula Capece; Gladys Posse; Cristina A Iovannitti; Alejandro D Nusblat; María L Cuestas
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-06       Impact factor: 4.813

6.  Summary of Guidelines for Managing Histoplasmosis among People Living with HIV.

Authors:  Freddy Perez; Diego H Caceres; Nathan Ford; Giovanni Ravasi; Beatriz L Gomez; Alessandro C Pasqualotto; Paul Hine; Antoine A Adenis; Mathieu Nacher; Tom Chiller; John Baddley
Journal:  J Fungi (Basel)       Date:  2021-02-12

7.  Miliary tuberculosis in an Indian lady: Looking beyond miliary tuberculosis.

Authors:  Arjun Lakshman; Varun Dhir; Narender Kumar; Manphool Singhal
Journal:  Lung India       Date:  2015 Sep-Oct

8.  Miliary nodules on chest radiographs: A diagnostic dilemma.

Authors:  Bharat Bhushan Sharma
Journal:  Lung India       Date:  2015 Sep-Oct

9.  Histoplasmosis in HIV-Infected Persons, Yaoundé, Cameroon.

Authors:  Christine E Mandengue; Antoinette Ngandjio; Paul J A Atangana
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

10.  Disseminated histoplasmosis and tuberculosis: dual infection in a non-endemic region.

Authors:  Karuna Anot; Sanjana Sharma; Monica Gupta; Daljinderjit Kaur
Journal:  BMJ Case Rep       Date:  2020-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.